Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
One year after Operation Sindoor showcased unprecedented coordination between the Army, Navy, and Air Force, India’s push for ...
When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
Luke White, the managing director of Damm's UK business discusses the growth opportunities he sees for the group in the country.
That’s the stark reality as articulated by Owen Ryan, CEO of Finance Management firm Blackline, reflective perhaps of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results